These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 39077486)

  • 21. Using ST2 in cardiovascular patients: a review.
    Daniels LB; Bayes-Genis A
    Future Cardiol; 2014 Jul; 10(4):525-39. PubMed ID: 25301315
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Galectin-3 and β-trace protein concentrations are higher in clinically unaffected patients with Fabry disease.
    Hernández-Romero D; Sánchez-Quiñones J; Vílchez JA; Rivera-Caravaca JM; de la Morena G; Lip GYH; Climent V; Marín F
    Sci Rep; 2019 Apr; 9(1):6235. PubMed ID: 30996283
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic value of cardiac biomarkers in the risk stratification of syncope: a systematic review.
    Thiruganasambandamoorthy V; Ramaekers R; Rahman MO; Stiell IG; Sikora L; Kelly SL; Christ M; Claret PG; Reed MJ
    Intern Emerg Med; 2015 Dec; 10(8):1003-14. PubMed ID: 26498335
    [TBL] [Abstract][Full Text] [Related]  

  • 24. DANSPOT: A Multicenter Stepped-Wedge Cluster-Randomized Trial of the Reclassification of Acute Myocardial Infarction: Rationale and Study Design.
    Strandkjær N; Jørgensen N; Hasselbalch RB; Kristensen J; Knudsen MSS; Kock TO; Lange T; Lindholm MG; Bruun NE; Holmvang L; Terkelsen CJ; Pedersen CK; Christensen MK; Lassen JF; Hilsted L; Ladefoged S; Nybo M; Bor MV; Dahl M; Hansen AB; Kamstrup PR; Bundgaard H; Torp-Pedersen C; Iversen KK
    J Am Heart Assoc; 2024 May; 13(9):e033493. PubMed ID: 38639348
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biomarkers to diagnose ventricular dysfunction in childhood cancer survivors: a systematic review.
    Leerink JM; Verkleij SJ; Feijen EAM; Mavinkurve-Groothuis AMC; Pourier MS; Ylänen K; Tissing WJE; Louwerens M; van den Heuvel MM; van Dulmen-den Broeder E; de Vries ACH; Ronckers CM; van der Pal HJH; Kapusta L; Loonen J; Bellersen L; Pinto YM; Kremer LCM; Kok WEM
    Heart; 2019 Feb; 105(3):210-216. PubMed ID: 30158136
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biomarkers in the Diagnosis, Management, and Prognostication of Perioperative Right Ventricular Failure in Cardiac Surgery-Are We There Yet?
    Jabagi H; Mielniczuk LM; Liu PP; Ruel M; Sun LY
    J Clin Med; 2019 Apr; 8(4):. PubMed ID: 31027170
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic and prognostic value of the sex-specific 99th percentile of four high-sensitivity cardiac troponin assays in patients with suspected myocardial infarction.
    Lehmacher J; Sörensen NA; Twerenbold R; Goßling A; Haller PM; Hartikainen TS; Schock A; Toprak B; Zeller T; Westermann D; Neumann JT
    Eur Heart J Acute Cardiovasc Care; 2024 Feb; 13(1):3-12. PubMed ID: 37890108
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel biomarkers for cardiovascular risk prediction.
    Wang J; Tan GJ; Han LN; Bai YY; He M; Liu HB
    J Geriatr Cardiol; 2017 Feb; 14(2):135-150. PubMed ID: 28491088
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Biomarker-guided personalised emergency medicine for all - hope for another hype?
    Schuetz P; Aujesky D; Müller C; Müller B
    Swiss Med Wkly; 2015; 145():w14079. PubMed ID: 25695147
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sex-Specific Cut-Offs for High-Sensitivity Cardiac Troponin: Is Less More?
    Romiti GF; Cangemi R; Toriello F; Ruscio E; Sciomer S; Moscucci F; Vincenti M; Crescioli C; Proietti M; Basili S; Raparelli V
    Cardiovasc Ther; 2019; 2019():9546931. PubMed ID: 31772621
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Diagnostic performance and optimal cut-off values of cardiac biomarkers for predicting cardiac injury in carbon monoxide poisoning.
    Park JH; Heo R; Kang H; Oh J; Lim TH; Ko BS
    Clin Exp Emerg Med; 2020 Sep; 7(3):183-189. PubMed ID: 33028061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antiretroviral therapy and HIV-associated cardiovascular disease: a prospective cardiac biomarker and CMR tissue characterization study.
    Robbertse PS; Doubell AF; Esterhuizen TM; Herbst PG
    ESC Heart Fail; 2024 Apr; 11(2):748-758. PubMed ID: 38100145
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Biomarkers in atrial fibrillation and heart failure with non-reduced ejection fraction: Diagnostic application and new cut-off points.
    Merino-Merino A; Saez-Maleta R; Salgado-Aranda R; AlKassam-Martinez D; Pascual-Tejerina V; Martin-Gonzalez J; Garcia-Fernandez J; Perez-Rivera JA
    Heart Lung; 2020; 49(4):388-392. PubMed ID: 32145960
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Normative Values of High-Sensitivity Cardiac Troponin T and N-Terminal pro-B-Type Natriuretic Peptide in Children and Adolescents: A Study from the CALIPER Cohort.
    Lam E; Higgins V; Zhang L; Chan MK; Bohn MK; Trajcevski K; Liu P; Adeli K; Nathan PC
    J Appl Lab Med; 2021 Mar; 6(2):344-353. PubMed ID: 32995884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Head-to-head comparison of 2 myocardial fibrosis biomarkers for long-term heart failure risk stratification: ST2 versus galectin-3.
    Bayes-Genis A; de Antonio M; Vila J; Peñafiel J; Galán A; Barallat J; Zamora E; Urrutia A; Lupón J
    J Am Coll Cardiol; 2014 Jan; 63(2):158-66. PubMed ID: 24076531
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Biomarkers of myocardial stress and fibrosis as predictors of mode of death in patients with chronic heart failure.
    Ahmad T; Fiuzat M; Neely B; Neely ML; Pencina MJ; Kraus WE; Zannad F; Whellan DJ; Donahue MP; Piña IL; Adams KF; Kitzman DW; O'Connor CM; Felker GM
    JACC Heart Fail; 2014 Jun; 2(3):260-8. PubMed ID: 24952693
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Predictive Ability of Novel Cardiac Biomarkers ST2, Galectin-3, and NT-ProBNP Before Cardiac Surgery.
    Polineni S; Parker DM; Alam SS; Thiessen-Philbrook H; McArthur E; DiScipio AW; Malenka DJ; Parikh CR; Garg AX; Brown JR
    J Am Heart Assoc; 2018 Jul; 7(14):. PubMed ID: 29982227
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Association of the biomarkers soluble ST2, galectin-3 and growth-differentiation factor-15 with heart failure and other non-cardiac diseases.
    Mueller T; Leitner I; Egger M; Haltmayer M; Dieplinger B
    Clin Chim Acta; 2015 May; 445():155-60. PubMed ID: 25850080
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Prognostication in Different Heart Failure Phenotypes: The Role of Circulating Biomarkers.
    Berezin AE
    J Circ Biomark; 2016; 5():6. PubMed ID: 28936254
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiovascular biomarkers as predictors of adverse outcomes in chronic Chagas cardiomyopathy.
    Echeverría LE; Rojas LZ; Gómez-Ochoa SA; Rueda-Ochoa OL; Sosa-Vesga CD; Muka T; Januzzi JL; Marcus R; Morillo CA
    PLoS One; 2021; 16(10):e0258622. PubMed ID: 34710112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.